Cardinal Health, Inc.


Market Cap$26.06B

Compare Cardinal Health

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cardinal Health, Inc.Cardinal Health, Inc.40.81.85%-19%0.1-1.4
marketMarket Avg49.61.28%30%6.11.1
IndustrialsIndustrials Avg19.10.99%21%3.10.6

Earnings Call Q3 2023

May 4, 2023 - AI Summary

Cardinal Health reported strong results for the third quarter of fiscal year 2023, with total revenue increasing by 13% to $50.5 billion and gross margin increasing by 6% to $1.8 billion.
The Pharma segment led the growth, with revenue increasing by 14% to $47 billion and segment profit increasing by 23% to $600 million. This was driven by strong demand for pharmaceutical products, particularly from large customers, as well as a higher contribution from brand and specialty products.
The Medical segment saw a decline in revenue of 5% to $3.7 billion and a significant decrease in segment profit of 66% to $20 million. This was primarily due to lower product volumes and unfavorable sales mix, although there were some positive non-recurring adjustments in the quarter.
Cardinal Health is focused on executing its medical improvement plan, which includes mitigating inflationary costs and driving growth in its Cardinal Health brand products. While progress has been made in mitigating inflation, the demand for Cardinal Health brand products has remained stagnant, impacting overall volume growth.
The company raised and narrowed its fiscal year 2023 EPS guidance range from $5.20-$5.50 to $5.60-$5.80, reflecting an improved outlook for the Pharmaceutical segment. However, the outlook for the Medical segment was revised downward, with a revenue decline of approximately 6% and a segment profit decline of approximately 50% expected for the full year.

Current Fair Value

9.2% upside

Undervalued by 9.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$26.06 Billion
Enterprise Value$26.19 Billion
Dividend Yield$1.9817 (1.85%)
Earnings per Share$2.53
Outstanding Shares243,233,153
Avg 30 Day Volume2,439,174


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio40.79
Price to Sales0.12
Price to Book Ratio-7.31
Enterprise Value to Revenue0.12
Enterprise Value to EBIT11.39
Enterprise Value to Net Income40
Total Debt to Enterprise0.18
Debt to Equity-1.37

Revenue Sources

No data

ESG Score

No data

About Cardinal Health, Inc.